Vaxcyte (PCVX) Other Accumulated Expenses (2019 - 2023)
Vaxcyte's Other Accumulated Expenses was $1.9 million in Q4 2023, up 34.7% from $1.41 million a year earlier but down 23.8% from the prior quarter.
Powered by 
Analysis
Vaxcyte (PCVX) Other Accumulated Expenses (2019 - 2023) Analysis & Trends
From Q4 2019 onward, Vaxcyte has reported Other Accumulated Expenses for 16 quarters.
- Other Accumulated Expenses shows a four-year compound annual growth rate of 133.4% (FY2019 to FY2023).
- In earlier years, Other Accumulated Expenses was $1.41 million in FY2022 (-61.4%), $3.66 million in FY2021 (+746.8%), $432,000 in FY2020 (+575.0%) and $64,000 in FY2019.
- Quarterly Other Accumulated Expenses has moved between $64,000 (Q4 2019) and $5.05 million (Q3 2021) over five years.
- Compared with a year earlier, Other Accumulated Expenses has increased for four straight quarters, with growth averaging 26.8% over the last eight quarters.
- The best year-over-year quarter for Other Accumulated Expenses over five years was Q4 2021 (growth of 746.8%); the worst was Q2 2022 (a decline of 76.7%).
- Per Business Quant data, PCVX's Other Accumulated Expenses in the three quarters before Q4 2023 was $2.49 million (Q3 2023), $1.91 million (Q2 2023) and $2.7 million (Q1 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Vaxcyte | 8.24 Bn | 8.24 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 1.90 Mn |
| Sep 30, 2023 | 2.49 Mn |
| Jun 30, 2023 | 1.91 Mn |
| Mar 31, 2023 | 2.70 Mn |
| Dec 31, 2022 | 1.41 Mn |
| Sep 30, 2022 | 1.58 Mn |
| Jun 30, 2022 | 925,000.00 |
| Mar 31, 2022 | 970,000.00 |
| Dec 31, 2021 | 3.66 Mn |
| Sep 30, 2021 | 5.05 Mn |
| Jun 30, 2021 | 3.97 Mn |
| Mar 31, 2021 | 671,000.00 |
| Dec 31, 2020 | 432,000.00 |
| Sep 30, 2020 | 415,000.00 |
| Jun 30, 2020 | 290,000.00 |
| Dec 31, 2019 | 64,000.00 |
API Access
Vaxcyte Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=PCVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "PCVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=PCVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();